Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen

From National Research Council Canada

Download
  1. (PDF, 3.6 MiB)
  2. (ZIP, 36.1 MiB)
DOIResolve DOI: https://doi.org/10.1080/22221751.2023.2251595
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: 1; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FunderSearch for: Canadian Institutes of Health Research; Search for: Independent Research Fund Denmark
FormatText, Article
SubjectHIV; immunodeficiency; vaccine; prophylaxis; NHP; T-cell; IFN-y
Abstract
Publication date
PublisherTaylor & Francis Group
Licence
In
LanguageEnglish
Peer reviewedYes
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier8e19e0a3-e3a2-4238-b356-b356ae9c79b4
Record created2024-07-23
Record modified2024-07-24
Date modified: